These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 2168280

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sensitivity of Chinese hamster ovary mutants defective in DNA double strand break repair to topoisomerase II inhibitors.
    Jeggo PA, Caldecott K, Pidsley S, Banks GR.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):7057-63. PubMed ID: 2479475
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hyperthermia can reduce cytotoxicity from etoposide without a corresponding reduction in the number of topoisomerase II-DNA cleavable complexes.
    Dynlacht JR, Wong RS, Albright N, Dewey WC.
    Cancer Res; 1994 Aug 01; 54(15):4129-37. PubMed ID: 8033146
    [Abstract] [Full Text] [Related]

  • 5. Attenuated topoisomerase II content directly correlates with a low level of drug resistance in a Chinese hamster ovary cell line.
    Webb CD, Latham MD, Lock RB, Sullivan DM.
    Cancer Res; 1991 Dec 15; 51(24):6543-9. PubMed ID: 1660341
    [Abstract] [Full Text] [Related]

  • 6. Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors.
    Pommier Y, Kerrigan D, Schwartz RE, Swack JA, McCurdy A.
    Cancer Res; 1986 Jun 15; 46(6):3075-81. PubMed ID: 3009009
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sister chromatid exchanges, chromosomal aberrations, and cytotoxicity produced by antitumor topoisomerase II inhibitors in sensitive (DC3F) and resistant (DC3F/9-OHE) Chinese hamster cells.
    Pommier Y, Kerrigan D, Covey JM, Kao-Shan CS, Whang-Peng J.
    Cancer Res; 1988 Feb 01; 48(3):512-6. PubMed ID: 2825977
    [Abstract] [Full Text] [Related]

  • 9. Effect of cellular ATP depletion on topoisomerase II poisons. Abrogation Of cleavable-complex formation by etoposide but not by amsacrine.
    Sorensen M, Sehested M, Jensen PB.
    Mol Pharmacol; 1999 Mar 01; 55(3):424-31. PubMed ID: 10051525
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antagonistic effect of aclarubicin on the cytotoxicity of etoposide and 4'-(9-acridinylamino)methanesulfon-m-anisidide in human small cell lung cancer cell lines and on topoisomerase II-mediated DNA cleavage.
    Jensen PB, Sørensen BS, Demant EJ, Sehested M, Jensen PS, Vindeløv L, Hansen HH.
    Cancer Res; 1990 Jun 01; 50(11):3311-6. PubMed ID: 2159380
    [Abstract] [Full Text] [Related]

  • 13. Hypertonic treatment does not affect the radiation yield of interphase chromosome breaks in DNA double-strand break repair-deficient xrs-5 cells.
    Okayasu R, Varlotto J, Iliakis G.
    Radiat Res; 1993 Aug 01; 135(2):171-7. PubMed ID: 8367588
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role of topoisomerase II beta in the resistance of 9-OH-ellipticine-resistant Chinese hamster fibroblasts to topoisomerase II inhibitors.
    Dereuddre S, Delaporte C, Jacquemin-Sablon A.
    Cancer Res; 1997 Oct 01; 57(19):4301-8. PubMed ID: 9331091
    [Abstract] [Full Text] [Related]

  • 16. The role of nonhomologous DNA end joining, conservative homologous recombination, and single-strand annealing in the cell cycle-dependent repair of DNA double-strand breaks induced by H(2)O(2) in mammalian cells.
    Frankenberg-Schwager M, Becker M, Garg I, Pralle E, Wolf H, Frankenberg D.
    Radiat Res; 2008 Dec 01; 170(6):784-93. PubMed ID: 19138034
    [Abstract] [Full Text] [Related]

  • 17. Additive and supraadditive interaction between ionizing radiation and pazelliptine, a DNA topoisomerase inhibitor, in Chinese hamster V-79 fibroblasts.
    Balosso J, Giocanti N, Favaudon V.
    Cancer Res; 1991 Jun 15; 51(12):3204-11. PubMed ID: 1645614
    [Abstract] [Full Text] [Related]

  • 18. Cytogenetical characterization of Chinese hamster ovary X-ray-sensitive mutant cells, xrs 5 and xrs 6. IV. Study of chromosomal aberrations and sister-chromatid exchanges by restriction endonucleases and inhibitors of DNA topoisomerase II.
    Darroudi F, Natarajan AT.
    Mutat Res; 1989 Jun 15; 212(2):137-48. PubMed ID: 2543922
    [Abstract] [Full Text] [Related]

  • 19. Enhanced amsacrine-induced mutagenesis in plateau-phase Chinese hamster ovary cells, with targeting of +1 frameshifts to free 3' ends of topoisomerase II cleavable complexes.
    Patteson K, Wang P, Povirk LF.
    Cancer Res; 1999 Aug 01; 59(15):3682-8. PubMed ID: 10446982
    [Abstract] [Full Text] [Related]

  • 20. Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells.
    Jensen LH, Dejligbjerg M, Hansen LT, Grauslund M, Jensen PB, Sehested M.
    BMC Pharmacol; 2004 Dec 02; 4():31. PubMed ID: 15575955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.